Vinge Logotype
Svenska English 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge advises Apax Partner’s portfolio company Destiny in connection with its acquisition of Soluno
Mandate

Vinge advises Apax Partner’s portfolio company Destiny in connection with its acquisition of Soluno

June 21, 2021 Employment and Benefits Commercial Agreements M&A IT, Telecommunications and Outsourcing Real Estate and Construction Corporate Crime & Compliance Intellectual Property

Vinge advises Destiny (a portfolio company of Apax Partners) in connection with its acquisition of the Soluno group (“Soluno”).

Soluno is one of the leading unified communications as a service providers in Europe. The acquisition gives Destiny an instantly strong position in Sweden and also leads to globalisation for Soluno. Following the acquisition, Destiny will comprise of more than 600 employees across 6 countries and is expected to generate a turnover of SEK 1.7 billion in 2021.

Vinge’s team mainly consisted of Christina Kokko, Ulrich Ziche, Hannah Kajlinger and Carl Fredrik Wachtmeister (M&A), Lisa Hörnqvist (Commercial Agreements and GDPR), Mathilda Persson (IT), Ulf Pyk (Real Estate), Josefine Lanker (Banking and Financing), Ebba Svenburg (Employment), Tove Lövgren Frisk (Compliance), Felizia Wiker (IP) and Sara Dahlroos Sköld (VDR specialist).

Related

Vinge advises Axcel VI and Currentum in connection with the acquisition of Elprojekt Skandinavien

 Vinge advises Axcel VI and the Currentum Group in connection with the acquisition of Elprojekt Skandinavien. The company provides complete electrical installations throughout Sweden, focusing on new construction of logistics properties, production facilities, residential buildings and office buildings. Elprojekt Skandinavien had a revenue of SEK 316 million in 2024.
June 23, 2025

Vinge advises Meribel Pharma Solutions

 Vinge advises Meribel Pharma Solutions in connection with the sale of a production facility specialising in the manufacture of antibiotics to Apotek Produktion & Laboratorier AB ("APL").
June 23, 2025

Vinge has advised Hansa Biopharma in connection with a directed share issue of approx. SEK 232 million and restructuring of debt financing

 Vinge has advised Hansa Biopharma AB (publ) in connection with a directed share issue, through which Hansa raises gross proceeds of approx. SEK 232 million, and restructuring of debt financing. As part of such debt restructuring, Hansa has in conjunction with the directed share issue set-off debt corresponding to approximately USD 14.9 million of its total debt amount.
June 23, 2025